Clairvest Invests US$25M in Boca Biolistics

Clairvest Group Inc., together with its Clairvest Equity Partners VI co-investment pool, made a US$25 million equity investment in Boca Biolistics, partnering with management (founders Valentin Adia and Michael Morris) who rolled a meaningful portion of their equity. Boca Biolistics is a clinical research organization and biobanking/biomaterials company that procures, stores and sells human biospecimens and also provides in-house analytical laboratory services; the capital will support the company’s next phase of growth and capability expansion.